St. Louis, MO, United States of America

Laurel Mydock-McGrane

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Fimbrion Therapeutics, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurel Mydock-McGrane. Retrieved from https://idiyas.com/inventor/laurel-mydock-mcgrane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Laurel Mydock-McGrane

Introduction

Laurel Mydock-McGrane is an accomplished inventor based in St. Louis, MO (US). She has made significant contributions to the field of medical science, particularly in the development of treatments for urinary tract infections. Her innovative work has led to the creation of valuable patents that address critical health issues.

Latest Patents

Laurel holds a patent for "Mannose-derived antagonists of FimH useful for treating disease." This invention relates to mannoside derivative compounds that serve as inhibitors of FimH, providing methods for the treatment or prevention of urinary tract infections. This patent highlights her commitment to advancing healthcare solutions.

Career Highlights

Laurel is currently associated with Fimbrion Therapeutics, Inc., where she continues to work on groundbreaking research and development projects. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative therapeutic solutions.

Collaborations

One of her notable collaborators is James Walter Janetka, with whom she has worked closely on various projects. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research.

Conclusion

Laurel Mydock-McGrane's contributions to the field of medical science through her patent and work at Fimbrion Therapeutics, Inc. demonstrate her dedication to improving healthcare. Her innovative spirit and collaborative efforts continue to pave the way for advancements in treatment options for urinary tract infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…